These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6462154)

  • 1. [Abbreviated treatment of tuberculosis. Experience in large cities].
    Yañez A; Valenzuela P
    Bol Oficina Sanit Panam; 1982 Feb; 92(2):127-42. PubMed ID: 6462154
    [No Abstract]   [Full Text] [Related]  

  • 2. [Relapse in tuberculosis].
    Kameda K
    Kekkaku; 1983 Feb; 58(2):73-80. PubMed ID: 6855045
    [No Abstract]   [Full Text] [Related]  

  • 3. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
    Page KR; Sifakis F; Montes de Oca R; Cronin WA; Doherty MC; Federline L; Bur S; Walsh T; Karney W; Milman J; Baruch N; Adelakun A; Dorman SE
    Arch Intern Med; 2006 Sep; 166(17):1863-70. PubMed ID: 17000943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Compliance, tolerance and effectiveness of a short chemoprophylaxis regimen for the treatment of tuberculosis].
    Martínez Alfaro E; Solera J; Serna E; Cuenca D; Castillejos ML; Espinosa A; Sáez L
    Med Clin (Barc); 1998 Oct; 111(11):401-4. PubMed ID: 9834911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of high- versus standard-dose rifampin in Indonesian patients with pulmonary tuberculosis.
    Ruslami R; Nijland H; Aarnoutse R; Alisjahbana B; Soeroto AY; Ewalds S; van Crevel R
    Antimicrob Agents Chemother; 2006 Feb; 50(2):822-3. PubMed ID: 16436757
    [No Abstract]   [Full Text] [Related]  

  • 6. A retrospective evaluation of completion rates, total cost, and adverse effects for treatment of latent tuberculosis infection in a public health clinic in central massachusetts.
    Young H; Wessolossky M; Ellis J; Kaminski M; Daly JS
    Clin Infect Dis; 2009 Aug; 49(3):424-7. PubMed ID: 19548835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
    Engbaek HC; Heckscher T; Højgaard C; Larsen SO; Rasmussen KN; Vergmann B
    Eur J Respir Dis; 1982 Mar; 63(2):84-93. PubMed ID: 7040100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Compliance, efficacy and tolerability of the therapeutic regimen recommended by National Consensus on Tuberculosis].
    Colmenero JD; García-Ordoñez MA; Sebastián MD; Pérez-Ruiz E; Sánchez-Lora J; Sánchez-González J; Bentabol G; Juárez C
    Enferm Infecc Microbiol Clin; 1997 Mar; 15(3):129-33. PubMed ID: 9235051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use and activity of rifomycin in local treatment of extrapulmonary tubercular forms].
    Zanotelli F
    Fracastoro; 1965; 58(5):353-61. PubMed ID: 5854786
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse drug reactions observed during DOTS.
    Dhingra VK; Rajpal S; Aggarwal N; Aggarwaln JK; Shadab K; Jain SK
    J Commun Dis; 2004 Dec; 36(4):251-9. PubMed ID: 16506547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of pulmonary tuberculosis of native Black Africans a chemotherapeutic regime including rifampicin (apropos of 75 patients)].
    Ayad M; Hane A; Kane PA
    Dakar Med; 1980; 25(1):65-74. PubMed ID: 7460740
    [No Abstract]   [Full Text] [Related]  

  • 12. Attitudes and knowledge of newly diagnosed tuberculosis patients regarding the disease, and factors affecting treatment compliance.
    Liam CK; Lim KH; Wong CM; Tang BG
    Int J Tuberc Lung Dis; 1999 Apr; 3(4):300-9. PubMed ID: 10206500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New approaches to the treatment of latent tuberculosis.
    Sterling TR
    Semin Respir Crit Care Med; 2008 Oct; 29(5):532-41. PubMed ID: 18810686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of short-term tuberculosis therapy with isoniazid, rifampicin and pyrazinamide].
    Brändli O; Dreher D; Morger D
    Schweiz Med Wochenschr; 1993 Jun; 123(25):1300-6. PubMed ID: 8341998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A regimen containing rifabutin for the treatment of tuberculosis in patients intolerant to rifampin.
    Tattevin P; Revest M; Dupont M; Arvieux C; Michelet C
    Clin Infect Dis; 2003 Jan; 36(1):127-8. PubMed ID: 12491218
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens.
    Jawahar MS; Rajaram K; Sivasubramanian S; Paramasivan CN; Chandrasekar K; Kamaludeen MN; Thirithuvathas AJ; Ananthalakshmi V; Prabhakar R
    Trop Med Int Health; 2005 Nov; 10(11):1090-8. PubMed ID: 16262733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Desensitization therapy for antituberculous drugs].
    Kobashi Y; Okimoto N; Matsushima T; Abe T; Nishimura K; Shishido S; Kawahara S; Shigeto E; Takeyama H; Kuraoka T
    Kekkaku; 2000 Sep; 75(9):521-6. PubMed ID: 11068368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis in the elderly: treating the "white plague".
    Iseman MD
    Geriatrics; 1980 Mar; 35(3):90-107. PubMed ID: 7353794
    [No Abstract]   [Full Text] [Related]  

  • 19. [The results of retreatment of pulmonary tuberculosis using a short 6-month protocol 1985-1991 in the pneumo-phthisiology department of the Point G hospital in Bamako].
    Kayantao D; Keïta B; Sangaré S
    Bull Soc Pathol Exot; 1997; 90(2):124-7. PubMed ID: 9289251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
    Li J; Munsiff SS; Driver CR; Sackoff J
    Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.